Clinical Trials Logo

Covid19 clinical trials

View clinical trials related to Covid19.

Filter by:

NCT ID: NCT04689464 Completed - Depression Clinical Trials

COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients

Start date: December 1, 2020
Phase:
Study type: Observational

The covid-19 pandemic started to spread worldwide since December 2019. It promoted to an exaggerated psychological stress and anxiety in humans due to the intolerable symptoms higher than usual death of many infected patients. This study examines the corona related anxiety and if there is need for drug intervention to treat this anxiety. To answer these questions, a survey made to the hospitalized patients including sex, age, educational level, Marital state, and a standardized questionnaires (GAD-7 and PHQ-9) which has been validated and shown to possess good psychometric qualities in studies of participants from multiple populations.

NCT ID: NCT04689399 Completed - Covid19 Clinical Trials

Sensitivity and Specificity of SARS-CoV-2 Rapid Antigen Test Compared to RT-PCR Test

Start date: December 26, 2020
Phase: N/A
Study type: Interventional

This project aims to investigate the sensitivity and specificity of the rapid antigen test compared to RT-PCR test performed on samples from the nasopharynx and the anterior nasal cavity and the oropharynx, respectively.

NCT ID: NCT04688372 Completed - Clinical trials for Volume Outcome Relationship Among COVID-19 Inpatients in US Hospitals

Hospital COVID-19 Surge and Associated Mortality Risk

Start date: October 1, 2020
Phase:
Study type: Observational

A retrospective cohort study will be conducted using a large administrative database of U.S. hospitals to understand the volume-outcome relationship among patients hospitalized with COVID-19.

NCT ID: NCT04686773 Completed - COVID-19 Clinical Trials

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

Start date: March 5, 2021
Phase: Phase 2
Study type: Interventional

The purpose of the study is to assess safety and immunogenicity of heterologous booster vaccine containing combination of AZD1222 and rAd26-S (one of components of Gam-COVID-Vac vaccine) in adult subjects aged ≥ 18 years old to prevent COVID-19 spread.

NCT ID: NCT04686734 Completed - Covid19 Clinical Trials

Long-term Effects of COVID-19 in Adolescents

LoTECA
Start date: January 6, 2021
Phase:
Study type: Observational

The overarching objective for this prospective cohort study of COVID-19 in adolescents is to study the long-term effects, with particular emphasis on post-infectious chronic fatigue. A total of 500 individuals with a SARS-CoV-2 positive test will be enrolled in the acute phase of COVID-19 and followed for 6 months. A total of 100 individuals with SARS-CoV-2 negative test will be included during the same time period as a control group. Investigations include autonomic, pulmonary and cognitive assessement; a questionnaire charting symptoms, emotionality, personality, loneliness, life events and demographics; and extensive biobanking including genetic markers, viable PBMC, urine, feces and hair. A subgroup of 40 SARS-CoV-2 positive and 20 SARS-CoV-2 negative individuals will also undergo detailed cardiological examination by echocardiography. Primary endpoints are fatigue at 6 months as assessed by the Chalder Fatigue Scale and post-COVID-19 syndrome cases at 6 months according to the WHO definition

NCT ID: NCT04686578 Recruiting - Fibromyalgia Clinical Trials

The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia

Start date: December 1, 2020
Phase:
Study type: Observational

The investigators planned to analyze the effect of Covid-19 fear and anxiety on the daily life, sleep quality and depression-anxiety levels of fibromyalgia patients.

NCT ID: NCT04686565 Recruiting - Covid19 Clinical Trials

Covid-19 Pandemic and Cerebral Palsy

Start date: February 15, 2020
Phase:
Study type: Observational

Investigator aimed to analyzed the effect of Covid-19 pandemic on the physical-psychosocial and cognitive state of the children, to benefit form the health, education services and the caregiver's quality of life with telemedicine.

NCT ID: NCT04686539 Recruiting - Covid19 Clinical Trials

Synthetic CBD as a Therapy for COVID-19

Start date: January 20, 2021
Phase: Phase 1
Study type: Interventional

The study aim to test proof of concept of CBD treatment for efficacy and safety in patients suffering with mild COVID-19 infection. The CBD will be delivered via oil droplets not containing THC, compared to placebo.

NCT ID: NCT04686409 Not yet recruiting - Clinical trials for Adverse Events in COVID-19 Vaccination

App-based Symptom Tracking After Corona Vaccination (CoCoV)

Start date: January 11, 2021
Phase:
Study type: Observational

The study investigates the side effects of different COVID-19 vaccines.

NCT ID: NCT04685681 Completed - Covid19 Clinical Trials

The Get Outside Study

GO
Start date: January 7, 2021
Phase: N/A
Study type: Interventional

The primary aim of this study is to examine whether lower-risk activities displace participation in higher-risk behaviors during COVID-19. Investigators will test this aim by promoting specific activities that are expected to be low-risk when it comes to COVID-19 transmission (e.g., participating in a hiking challenge) and assessing impacts on participants' activity choices. Investigators also aim to describe adults' activity participation during COVID-19 generally and to examine secondary outcomes, including reported stress and sleep.